Kiora Pharmaceuticals, Inc. (KPRX)
NASDAQ: KPRX · Real-Time Price · USD
2.330
+0.010 (0.43%)
At close: Apr 28, 2026, 4:00 PM EDT
2.370
+0.040 (1.72%)
After-hours: Apr 28, 2026, 6:53 PM EDT

Kiora Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Market Capitalization
107104619
Upgrade
Market Cap Growth
31.11%-27.03%146.53%-34.81%-67.75%-29.68%
Upgrade
Enterprise Value
-6-12-19-118
Upgrade
Last Close Price
2.331.973.304.7030.87543.60
Upgrade
PE Ratio
--2.76---
Upgrade
PS Ratio
--0.62---
Upgrade
PB Ratio
0.540.450.380.660.541.31
Upgrade
P/TBV Ratio
0.630.450.380.670.551.33
Upgrade
P/FCF Ratio
--1.16---
Upgrade
P/OCF Ratio
--1.16---
Upgrade
Debt / Equity Ratio
0.020.020.000.020.010.01
Upgrade
Debt / EBITDA Ratio
--0.01---
Upgrade
Debt / FCF Ratio
--0.01---
Upgrade
Net Debt / Equity Ratio
-1.04-1.04-1.04-0.38-0.51-0.52
Upgrade
Net Debt / EBITDA Ratio
1.771.77-4.770.270.550.73
Upgrade
Net Debt / FCF Ratio
1.661.66-3.130.250.560.71
Upgrade
Asset Turnover
--0.64---
Upgrade
Quick Ratio
5.625.624.602.762.245.21
Upgrade
Current Ratio
5.995.994.942.902.355.59
Upgrade
Return on Equity (ROE)
-51.74%-51.74%22.56%-142.88%-104.54%-113.30%
Upgrade
Return on Assets (ROA)
-19.47%-19.47%13.90%-33.54%-34.55%-37.30%
Upgrade
Return on Invested Capital (ROIC)
-664.93%-254.39%-186.67%-171.87%-131.74%
Upgrade
Return on Capital Employed (ROCE)
-45.90%-45.90%18.30%-72.00%-69.60%-57.10%
Upgrade
Earnings Yield
-105.95%-149.95%36.30%-311.53%-220.45%-72.08%
Upgrade
FCF Yield
-98.49%-139.39%86.37%-237.92%-169.24%-56.21%
Upgrade
Buyback Yield / Dilution
-1.01%-1.01%-666.73%-561.21%-203.73%-110.04%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.